Pfizer Must Face Suit on Rezulin, Court Says
- Share via
From Bloomberg News
Pfizer Inc. must face a class-action suit in West Virginia over its Rezulin diabetes drug’s role in destroying some patients’ livers, a state appeals court ruled.
The West Virginia Supreme Court reversed a lower court ruling denying 5,000 former Rezulin users the right to join together to sue the drug maker over the costs of monitoring their health in the future.
Pfizer’s shares fell 9 cents to $34.31 on the NYSE.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
